Synthesis and biological evaluation of 6-phenylpurine linked hydroxamates as novel histone deacetylase inhibitors

This publication has 37 references indexed in Scilit:

• Mechanisms of resistance to sorafenib and the corresponding strategies in hepatocellular carcinoma
  World Journal of Hepatology, 2013
• Preclinical Metabolism and Disposition of SB939 (Pracinostat), an Orally Active Histone Deacetylase Inhibitor, and Prediction of Human Pharmacokinetics
  Drug Metabolism and Disposition, 2011
• Activation of Phosphatidylinositol 3-Kinase/Akt Signaling Pathway Mediates Acquired Resistance to Sorafenib in Hepatocellular Carcinoma Cells
  The Journal of Pharmacology and Experimental Therapeutics, 2011
• Acylurea connected straight chain hydroxamates as novel histone deacetylase inhibitors: Synthesis, SAR, and in vivo antitumor activity
  Bioorganic & Medicinal Chemistry Letters, 2010
• New patented histone deacetylase inhibitors
  Expert Opinion on Therapeutic Patents, 2009
• Biological properties of potent inhibitors of class I phosphatidylinositide 3-kinases: from PI-103 through PI-540, PI-620 to the oral agent GDC-0941
  Molecular Cancer Therapeutics, 2009
• AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading
  Journal of Computational Chemistry, 2009
• N-Hydroxy-1,2-disubstituted-1H-benzimidazol-5-yl acrylamides as novel histone deacetylase inhibitors: Design, synthesis, SAR studies, and in vivo antitumor activity
  Bioorganic & Medicinal Chemistry Letters, 2009
• Akt inactivates ERK causing decreased response to chemotherapeutic drugs in advanced CaP cells
  Cell Cycle, 2008
• Development and validation of high‐performance liquid chromatography–tandem mass spectrometry assay for 6‐(3‐benzoyl‐ureido)‐hexanoic acid hydroxyamide, a novel HDAC inhibitor, in mouse plasma for pharmacokinetic studies
  Biomedical Chromatography, 2007